← All trials
NCT02270489
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 11, 2014
- Primary completion
- Apr 18, 2017
- Completion date
- Apr 18, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Affiris AGLead sponsor
- Forschungszentrum JülichCollaborator
- University of BordeauxOverall official - principal investigator
- Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator
- University of BordeauxCollaborator
- University of ToulouseCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.